Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID‐19 vaccination – A case report
| Autor: | Alain Michon |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
medicine.medical_specialty Filler (packaging) COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) Original Contributions Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Cosmetic Techniques Dermatology Dermal Fillers Covid immunology chemistry.chemical_compound hyaluronic acid Hyaluronic acid medicine Humans Intradermal injection intradermal injection SARS-CoV-2 business.industry Vaccination filler COVID-19 Soft tissue chemistry Female hypersensitivity business dermal filler |
| Zdroj: | Journal of Cosmetic Dermatology |
| ISSN: | 1473-2165 1473-2130 |
| DOI: | 10.1111/jocd.14312 |
| Popis: | Background The use of hyaluronic acid soft tissue fillers in aesthetic medicine exploded in recent years for many reasons, including being relatively safe. Incidence of delayed inflammatory reactions (DIRs) to hyaluronic acid soft tissue fillers range between 0.3% and 4.25%. These reactions are mediated by T‐lymphocytes and can be triggered by flu‐like illnesses, including SARS‐CoV‐2 infection. Vaccination may also induce hypersensitivity. Aim In this case report, we present two cases of delayed reaction after hyaluronic acid soft tissue filler treatment of the tear trough area and following mRNA vaccination against SARS‐Cov‐2, also known as COVID‐19, months later. Patients A 39‐year old female who previously had her tear trough area treated with hyaluronic acid soft tissue filler developed swelling days after getting the mRNA Pfizer‐BioNTech COVID‐19 vaccine. Another patient, a 61‐year‐olf female, developed intermittent facial swelling in areas previously treated with hyaluronic acid soft tissue fillers days after receiving her first dose of the mRNA Pfizer‐BioNTech COVID‐19 vaccine. Results As demonstrated in our case report, vaccination against COVID‐19 may induce DIRs in patients who previously had hyaluronic soft tissue fillers. Conclusion Delayed inflammatory reactions to hyaluronic acid soft tissue fillers are uncommon and usually self‐limited, with frequent spontaneous resolution. However, considering the ongoing pandemic and the worldwide demand for vaccines against COVID‐19, the aesthetic providers should be conscious of the risks posed by the interaction of such vaccines in patients who previously had or seeking hyaluronic acid soft tissue filler injections. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|